FDA Inspection 1122732 — Jose Gerardo Gonzalez Gonzalez, M.D., Ph.D.

Jose Gerardo Gonzalez Gonzalez, M.D., Ph.D. — FEI 3015874064

The FDA completed an inspection of Jose Gerardo Gonzalez Gonzalez, M.D., Ph.D. on January 16, 2020 in Monterrey. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 16, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Monterrey (Mexico)

Additional Details

Clinical Investigator (CI)